This is one of those teases that clearly jumps out at people — when a relatively high profile newsletter teases a new and undervalued oil reservoir held by a tiny penny stock, folks get interested … or at least, that’s what I conclude from the vast number of emails I’ve received in just the last […]
Articles
- Most Relevant
- Most Recent
Yesterday I started looking through the first pitch from Stansberry alum Kim Iskyan as he launches his Truewealth publishing and Alpha Asia Advisory newsletter, and today I’m following through to look at the other stocks he pitched. Part one is here if you’d like to start at the beginning — the most full-throated bit of […]
“The New Alaskan ‘Oil Gush’ Is Underway… “Forget the greedy oil tycoons of Iraq, Saudi Arabia and Iran… Forget the oil giants Exxon, BP and Chevron… “This Tiny Exploration Company could deliver you a quick and early retirement…” That’s the intro from Chris Mayer in our newest tease — he’s trying to recruit new subscribers […]
Today we’re going to start you out with a quickie teaser solution, and I’m going to keep it quick mostly because this one is largely a connect-the-dots guess, given the limited number of clues that were dropped in the ad. The ad is from Marin Katusa, who went off on his own after leaving Casey […]
How’s that for a promise, eh? 1,173% — not just a great return, but a remarkably specific prediction. Will it come true? Well, let’s see if we can figure out what they’re talking about — the ad is for a special report that Sara Nunnally is pitching, published by the folks at Taipan, called “Gain […]
The latest Keith Kohl ad caught my eye, since I’ve been interested in cobalt for a while now and figured that “blue gold” probably means he’s teasing that metal … so what’s the story, is it cobalt he’s talking about, and what’s the cobalt-related investment that he thinks will make us 1,000%-type gains? Well, he […]
It’s fair to say that we get more than our share of teasers for commodity and natural resources stocks here at Stock Gumshoe — those kinds of stocks take up a big chunk of the newsletter world, with only tech stocks and biotech maybe keeping up. They’re areas where it’s easy to have (or pretend […]
The hook of Tyler Laundon’s ad for his Cabot Small-Cap Confidential newsletter is a 1,290% gain over the next three years… “When your grandchildren ask you how you turned nearly every $10,000 you invested in 2018 into $129,000 in just three years, I want you to be able to say, quite simply: Cabot Small-Cap Confidential.” And […]
Christian DeHaemer has made quite a career out of picking somewhat controversial resource companies with tiny market caps in war-torn or politically unstable or distasteful areas of the world — and since two of them that he has teased in the past, Petro Matad in Mongolia and Dragon Oil in Turkmenistan, have done very very […]
Zach Scheidt is pitching his Lifetime Income Report ($49) newsletter by hinting at some more big 5G winners — and while there’s probably not a whole lot new in the four stocks he’s teasing, since most of the 5G stocks have been discussed to death as we wait for the surge of next-generation profits to […]
[ed. note: We’re getting questions about this ad, so perhaps it’s circulating again — to help answer those questions, we’re re-posting this article that we originally published last November when we saw the first version of this ad. The Irregulars Quick Take has been updated above, but what follows has not been updated, changed or […]
“Tesla is building the largest battery factory ever… “Groundbreaking is expected any day now. You could see… “GigaProfits! “It doesn’t matter what you think about electric cars… You could make a fortune off Tesla’s new $5 billion ‘Gigafactory’ — Even if it’s a colossal failure. “One tiny resource company is essential to the Gigafactory. Here’s […]
Bonner & Partners, which is yet another publisher subsidiary of Bill Bonner’s Agora empire, has a new teaser pitch out for Jeff Brown’s Exponential Tech Investor — and what caught the eye of Gumshoe readers was the headline, in the ad from Bonner’s Managing Director Amber Lee Mason, that promises huge gains from a “$39 […]
This appears to be the “hot” story of the day, given the number of alert Gumshoe readers who have been forwarding it along (you can always submit your teasers, too, or forward them to ILoveStockSpam[at]gmail.com — the more the merrier!) — it’s from Wall Street Daily and is selling their Publisher’s Series as a quarterly offering […]
The latest pitch from Breakthrough Technology Alert, the high-priced tech “upgrade” newsletter from Agora Financial, is certainly over the top… this is how it opens: “Witness a Miracle Made Real “A shocking, exclusive video below reveals the most urgent market story of your lifetime. “Your fast action today could kick off lasting generations of wealth […]
Pain management is a huge market in the medical world, as you’re no doubt aware — and buckets of money are pouring down on the many, many little biotech stocks who are trying to develop new pain medications, or to tweak existing medications to make them safer or less likely to be abused. So it’s […]
This article first ran on September 15, 2014, when almost exactly the same ad was sent around teasing Cabot’s September “Stock of the Month” … … now, in February, they’re just calling it the “Top Stock of the Month.” Not much in the ad has changed, and the stock is about 10% cheaper now than […]
Growth stocks get all the attention these days, what with talk of a final “melt up” in the market before things finally return to rationality, and “value stocks” have been floundering for years as they’ve failed to capture the attention of investors… so last fall we saw a lot of predictions about the “turn,” the […]
“This $2 American company is threatening a massive Wall Street shakeup handing you the opportunity for… 403% Gains In 3 Months“ Who can resist that pitch, right? The ad comes from Manny Backus for his Penny Stocks Guru service, which has been promoted in the past as a way to buy “safe penny stocks.” An […]
Time once again, dear children, for a tale from the Middle Kingdom. Once upon a time, there was a nation so vast and populous that investors got dollar signs in their eyes just gazing upon the smoggy mega-cities that grew like weeds in that distant land. And lo, it was told that it was just […]
I didn’t do anything with my portfolio this week, and I don’t think we’ve had significant news that changes my opinion about any of the stocks I wrote about in our Annual Review about ten days ago, so today I’ll just dig into a teaser pitch for your Friday File edutainment. Here’s the intro to […]
This ad has been running again and generating a lot of questions from Gumshoe readers, so we’re re-posting the answer here. The article below has not been updated or revised since it was published on July 20, 2015, other than an update to the Irregulars “Quick Take” box and an updated disclosure at the bottom […]
[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]
The pitch I got from Keith Kohl and Jeff Siegel for Green Chip Stocks is a great example of storytelling — Kohl catches your eye with that headline that says “Warren Buffett’s in, are YOU?”, and then links to a spiel from Siegel that talks about how “free electricity” ran some telegraph lines during a […]
The “Internet of Things” is sure getting a lot of attention these days — most people throw around the forecasted numbers of $17-20 trillion as the market for this new technology, in which everything is interconnected and data is collected about you and your appliances and the roads you drive on and, well, everything. Even […]
10/28 update: this article is about a week old, but the teaser ads have changed a bit — the newsletter is now also being pitched under the headline, “Has this Maine town bottled the fountain of youth?” and it’s now also going out under the name Dr. Richard Robinson, who apparently works on the newsletter […]
I know I’ve said this before, and sometimes it’s a lie: I’m going to try to keep this one brief. Agora Financial’s FDA Trader service has a new pitch out — which normally might not get that much attention, since everyone is suddenly terrified of biotech stocks after a brutal month or two — but […]
James AltucherVia Stansberry, James Altucher is teasing a $2500 investment letter touting substantial gain saying he is connected to the early phase investors. Thoughts?
It’s been a heckuva week, eh? I have no idea whether this is really the “capitulation” washout that so many investing pundits have been looking for, or whether we’ll keep falling on Monday or will bounce back after the week ended so roughly, but I do have a couple thoughts to share with you about […]
Lots of questions about this one, so as I run out to a meeting today I’m re-releasing it for you — Navellier’s pitch is in heavy circulation again, and the ad is still touting the same stock as his similar ads of a month ago. The article below first ran on July 16, when the […]
I know, I know, I’m cynical — but yes, we can probably start out by responding to that headline question with a “probably not.” But that doesn’t mean we don’t care what they’re talking about in this latest ad — this time, the pitch comes from Jimmy Mengel for his The Crow’s Nest letter — […]
I’ve got no shortage of possible topics to write about after a couple weeks respite — the teasers didn’t stop flowing while I was gone, and the hyperbole hasn’t been turned down for the sultry days of summer — but the one that’s been requested most has been the “Einstein’s Space Energy” pitch from Dr. […]
Have you seen the teaser pitch from Amber Hestla about her little-known strategy for becoming a “stock landlord” and earning income by renting out your shares? It sounds appealing, and like the kind of thing you imagine the big investors must be doing to get an edge, right? Well, sort of — let’s look at […]
This newsletter has been closed.
[Ed note: This article was originally published in June, 2013 when the shares of the stock teased, Alnylam (ALNY) were around $30 and the Oxford Club was saying that the first person to live to 1,000 is already alive … now they’re touting it as the holder of the “Magic” Keys to Immortality, but the […]
I’ve got a few stocks to mention in the medical space this week — one to update that’s in my portfolio, one to confirm as a teaser pick (since folks keep asking) after several Gumshoe readers discussed it last week, and one to note as a teaser idea that’s being pushed pretty heavily (though the […]
This teaser pitch is from Manny Backus, who is promoting a new(ish) service called Triple Digit Returns — which looks like it’s a weekly advisory that recommends a different stock each week for 100%+ potential gains. This ad has been circulating since early in the year, and continues to drive questions to our inbox today […]
We continue to see worrisome commentary about market valuations, with hand-wringing about whether the stock market is overvalued or might be in a bubble… and it can get a bit draining, frankly. Caution is important, diversification is important, but worrying does us little good. Yes, investors are paying a steep price for anticipated growth in […]
How about something on Stansberry’s latest – “Pinpoint Surgery” stock?
Maybe the scariest thing I can tell you is, “I’m not selling everything.” The drumbeat in my head continues to be one of worry, I continue to be a little bit surprised at how high stocks are going, and how resilient stocks are. But thankfully, I haven’t been acting on those macro worries — because […]